Status:
ENROLLING_BY_INVITATION
ECG Low Ejection Fraction Detection and Guiding in AI Navigated Treatment Era
Lead Sponsor:
National Defense Medical Center, Taiwan
Conditions:
Heart Failure
Ventricular Dysfunction, Left
Eligibility:
All Genders
60-85 years
Phase:
NA
Brief Summary
Asymptomatic left ventricular systolic dysfunction (ALVSD), identified as a key component of stage B heart failure (HF) by AHA/ACC guidelines, is a common precursor to clinically overt HF. This progre...
Eligibility Criteria
Inclusion
- Outpatients with at least one 12-lead ECG
- Age between 60-85 years
Exclusion
- Documented echocardiography within the previous 6 months
- Known severe LV dysfunction (LVEF \<40%)
- Known heart failure history
- Scheduled echocardiography exam
Key Trial Info
Start Date :
June 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2027
Estimated Enrollment :
13350 Patients enrolled
Trial Details
Trial ID
NCT06968533
Start Date
June 1 2024
End Date
June 1 2027
Last Update
May 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tri-Service General Hospital, National Defense Medical Center
Taipei, Taiwan, 11490